US92337F1075
US92337F1075
Veracyte, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 3.64B EUR | 4.72B EUR | 2.57B EUR | 3.34B EUR |
Enterprise Value | 3.06B EUR | 4.46B EUR | 2.35B EUR | 3.02B EUR |
Valuation Multiples | ||||
Trailing P/E | 32.31x | 41.23x | 29.2x | 56.34x |
Forward P/E | 23.25x | -- | -- | -- |
Price to Sales | 6.47x | 8.4x | 4.74x | 8.3x |
Price to Book | 2.62x | 3.4x | 1.91x | 2.55x |
EV/Revenue | 5.45x | 7.94x | 4.33x | 7.5x |
EV/EBITDA | 26.96x | 30.2x | 16.77x | 28.88x |
Price to FCF (P/FCF) | 34.23x | 28.43x | 16.54x | 27.14x |
EV/FCF | 28.8x | 26.87x | 15.1x | 24.52x |
FCF Yield | 2.92% | 3.52% | 6.04% | 3.68% |